Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
3,981
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer

Mathias Vormehra BioNTech RNA Pharmaceuticals, Mainz, Germany;b Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, Mainz, GermanyORCID Iconhttps://orcid.org/0000-0001-7788-3380
ORCID Icon,
Sophie Leharc Genentech Inc., South San Francisco, CA, USA
,
Lena M. Kranza BioNTech RNA Pharmaceuticals, Mainz, GermanyORCID Iconhttps://orcid.org/0000-0003-1943-3431
ORCID Icon,
Siri Tahtinenc Genentech Inc., South San Francisco, CA, USA
,
Yoko Oeic Genentech Inc., South San Francisco, CA, USA
,
Vincent Javinal
,
Lélia Delamarrec Genentech Inc., South San Francisco, CA, USAORCID Iconhttps://orcid.org/0000-0001-9122-5181
ORCID Icon,
Kerstin C. Walzerd BioNTech SE, Mainz, Germany
,
Mustafa Dikena BioNTech RNA Pharmaceuticals, Mainz, Germany;e TRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany
,
Sebastian Kreitera BioNTech RNA Pharmaceuticals, Mainz, Germany;e TRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany
,
Ira Mellmanc Genentech Inc., South San Francisco, CA, USA
,
Ugur Sahinb Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany;e TRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany;d BioNTech SE, Mainz, Germany
,
Jill M. Schartnerc Genentech Inc., South San Francisco, CA, USA
&
Özlem Türecid BioNTech SE, Mainz, GermanyCorrespondence[email protected]
 show all
Article: 1758004 | Received 27 Oct 2019, Accepted 25 Mar 2020, Published online: 13 May 2020

  • Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP. Glucocorticoid Therapy and Adrenal Suppression. Endotext. 2000. [accessed 2020 April 27]. www.endotext.org
  • Meijsing SH. Mechanisms of Glucocorticoid-Regulated Gene Transcription. Adv Exp Med Biol. 2015;872:59–12. doi:10.1007/978-1-4939-2895-8_3.
  • Petta I, Dejager L, Ballegeer M, Lievens S, Tavernier J, De BK, Libert C. The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases. Microbiol Mol Biol Rev. 2016;80(2):495–522. doi:10.1128/MMBR.00064-15.
  • Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008;4(10):525–533. doi:10.1038/ncprheum0898.
  • Shih A, Jackson KC. Role of corticosteroids in palliative care. J Pain Palliat Care Pharmacother. 2007;21(4):69–76. doi:10.1080/J354v21n04_14.
  • Chen DS, Mellman I. Elements of cancer immunity and the cancer–immune set point. Nature. 2017;541(7637):321–330. doi:10.1038/nature21349.
  • Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov. 2019:1. doi:10.1038/s41573-018-0007-y.
  • Vormehr M, Türeci Ö, Sahin U. Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines. Annu Rev Med. 2019;70(1):395–407. doi:10.1146/annurev-med-042617-101816.
  • Wong ET, Lok E, Gautam S, Swanson KD. Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer. 2015;113(11):1642. doi:10.1038/bjc.2015.404.
  • Klement RJ, Champ CE. Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels. Brain. 2017;140(3):e16. doi:10.1093/brain/aww324.
  • Shields LBE, Shelton BJ, Shearer AJ, Chen L, Sun DA, Parsons S, Bourne TD, LaRocca R, Spalding AC. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients. Radiat Oncol. 2015;10(1):222. doi:10.1186/s13014-015-0527-0.
  • Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, et al. Corticosteroids compromise survival in glioblastoma. Brain. 2016;139(Pt 5):1458–1471. doi:10.1093/brain/aww046.
  • Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai WV, Hendriks LEL, et al. Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer. J Clin Oncol. 2018;36(28):2872–2878. doi:10.1200/JCO.2018.79.0006.
  • Maxwell R, Luksik AS, Garzon-Muvdi T, Hung AL, Kim ES, Wu A, Xia Y, Belcaid Z, Gorelick N, Choi J, et al. Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system. Oncoimmunology. 2018;7(12):e1500108. doi:10.1080/2162402X.2018.1500108.
  • Tokunaga A, Sugiyama D, Maeda Y, Warner AB, Panageas KS, Ito S, Togashi Y, Sakai C, Wolchok JD, Nishikawa H. Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids. J Exp Med. 2019 Sep 19;216(12):2701–2713. jem.20190738. doi:10.1084/jem.20190738.
  • Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, S L, J C, J C, Lu M, et al. Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019;25(9):1428–1441. doi:10.1038/s41591-019-0566-4.
  • Kuhn AN, Diken M, Kreiter S, Selmi A, Kowalska J, Jemielity J, Darzynkiewicz E, Huber C, Türeci O, Sahin U. Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther. 2010;17(8):961–971. doi:10.1038/gt.2010.52.
  • Strenkowska M, Grzela R, Majewski M, Wnek K, Kowalska J, Lukaszewicz M, Zuberek J, Darzynkiewicz E, Kuhn AN, Sahin U, et al. Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential. Nucleic Acids Res. 2016;gkw896. doi:10.1093/nar/gkw896.
  • Warminski M, Kowalska J, Buck J, Zuberek J, Lukaszewicz M, Nicola C, Kuhn AN, Sahin U, Darzynkiewicz E, Jemielity J. The synthesis of isopropylidene mRNA cap analogs modified with phosphorothioate moiety and their evaluation as promoters of mRNA translation. Bioorg Med Chem Lett. 2013;23(13):3753–3758. doi:10.1016/j.bmcl.2013.05.001.
  • Orlandini von Niessen AG, Poleganov MA, Rechner C, Plaschke A, LM K, Fesser S, Diken M, Löwer M, Vallazza B, Beissert T, et al. Improving mRNA-based therapeutic gene delivery by expression-augmenting 3ʹ UTRs identified by cellular library screening. Mol Ther. 2019;27(4):824–836. doi:10.1016/j.ymthe.2018.12.011.
  • Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Türeci O, Sahin U. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood. 2006;108(13):4009–4017. doi:10.1182/blood-2006-04-015024.
  • Kreiter S, Selmi A, Diken M, Türeci Ö, Sahin U, Sebastian M, Osterloh P, Schild H, Huber C, Türeci O, et al. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J Immunol. 2008;180(5):309–318. 180/1/309 [pii]. doi:10.4049/jimmunol.180.1.309.
  • Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534(7607):396–401. doi:10.1038/nature18300.
  • Kranz LM, Diken M, Fritz D, Haas H, Holzmann M, Meng M, Reuter K, Roth R, Selmi A, Kreiter S, et al. Abstract: Novel RNA-lipoplexes with immunostimulatory and targeting properties induce potent anti-tumoral immunity. 43rd Annu. Meet. Ger. Soc. Immunol. (DGfI), Mainz. 2013.
  • Kranz LM, Diken M, Fritz D, Haas H, Holzmann M, Meng M, Reuter K, Roth R, Selmi A, Kreiter S, et al. Abstract: Characterization of the IFNα response upon systemic administration of targeted mRNA vaccines. 12th Annu. Meet. Cancer Immunother. (CIMT), Mainz. 2014.
  • Jabulowsky RA, Loquai C, Diken M, Kranz LM, Haas H, Attig S, Britten CM, Buck J, Derhovanessian E, Diekmann J, et al. Abstract B041: A novel nanoparticular formulated tetravalent RNA cancer vaccine for treatment of patients with malignant melanoma. Cancer Immunol Res. 2016;4(1 Supplement):B041–B041. doi:10.1158/2326-6074.CRICIMTEATIAACR15-B041.
  • Jabulowsky RA, Loquai C, Diken M, Kranz LM, Haas H, Attig S, Bidmon N, Buck J, Derhovanessian E, Diekmann J, et al. Abstract CT032: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanoma. Cancer Res. 2016;76(14 Supplement):CT032–CT032. doi:10.1158/1538-7445.AM2016-CT032.
  • Jabulowsky RA, Loquai C, Utikal J, Hassel J, Kaufmann R, Derhovanessian E, Diken M, Kranz LM, Haas H, Attig S, et al. Abstract CT034: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy. Cancer Res. 2017;77(13 Supplement):CT034–CT034. doi:10.1158/1538-7445.AM2017-CT034.
  • Heesen L, Jabulowsky R, Loquai C, Utikal J, Gebhardt C, Hassel J, Kaufmann R, Pinter A, Derhovanessian E, Diken M, et al. 49PA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy. Ann Oncol. 2017;28(suppl_11):xi14–xi15. doi:10.1093/annonc/mdx711.030.
  • Jabulowsky RA, Loquai C, Mitzel-Rink H, Utikal J, Gebhardt C, Hassel JC, Kaufmann R, Pinter A, Derhovanessian E, Anft C, et al. Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. Cancer Res. 2018;78(13 Supplement):CT156–CT156. doi:10.1158/1538-7445.AM2018-CT156.
  • Pektor S, Hilscher L, Walzer KC, Miederer I, Bausbacher N, Loquai C, Schreckenberger M, Sahin U, Diken M, Miederer M. In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET. EJNMMI Res. 2018;8(1):80. doi:10.1186/s13550-018-0435-z.
  • Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520(7549):692–696. doi:10.1038/nature14426.
  • Slansky JE, Rattis FM, Boyd LF, Fahmy T, Jaffee EM, Schneck JP, Margulies DH, Pardoll DM. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity. 2000;13(4):529–538. doi:10.1016/S1074-7613(00)00052-2.
  • Yadav M, Jhunjhunwala S, Phung QT, Lupardus P, Tanguay J, Bumbaca S, Franci C, Cheung TK, Fritsche J, Weinschenk T, et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature. 2014;515(7528):572–576. doi:10.1038/nature14001.
  • Capietto A-H, Jhunjhunwala S, Pollock SB, Lupardus P, Wong J, Hänsch L, Cevallos J, Chestnut Y, Fernandez A, Lounsbury N, et al. Mutation position is an important determinant for predicting cancer neoantigens. J Exp Med. 2020;217(4):4. doi:10.1084/jem.20190179.
  • Dolton G, Tungatt K, Lloyd A, Bianchi V, SM T, Trimby A, CJ H, Donia M, AJ G, DK C, et al. More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers. Immunology. 2015;146(1):11–22. doi:10.1111/imm.12499.
  • Castle JC, Loewer M, Boegel S, de Graaf J, Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics. 2014;15(1):190. doi:10.1186/1471-2164-15-190.
  • Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32(1):659–702. doi:10.1146/annurev-immunol-032713-120145.
  • Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function*. Annu Rev Immunol. 2000;18(1):309–345. doi:10.1146/annurev.immunol.18.1.309.
  • Samtani MN, Jusko WJ. Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration. Biopharm Drug Dispos. 2005;26(3):85–91. doi:10.1002/bdd.435.
  • Rohdewald P, Möllmann H, Barth J, Rehder J, Derendorf H. Pharmacokinetics of dexamethasone and its phosphate ester. Biopharm Drug Dispos. 1987;8(3):205–212. doi:10.1002/bdd.2510080302.
  • Engler JB, Kursawe N, Solano ME, Patas K, Wehrmann S, Heckmann N, Lühder F, Reichardt HM, Arck PC, Gold SM, et al. Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy. Proc Natl Acad Sci U S A. 2017;114(2):E181–E190. doi:10.1073/pnas.1617115114.
  • Chen X, Murakami T, Oppenheim JJ, Howard OMZ. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol. 2004;34(3):859–869. doi:10.1002/eji.200324506.
  • Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-malefyt R, Coffman RL, Hawrylowicz CM, O’Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 2002;195(5):603–616. doi:10.1084/jem.20011629.
  • Franchimont D, Galon J, Gadina M, Visconti R, Zhou Y, Aringer M, Frucht DM, Chrousos GP, O’Shea JJ. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol. 2000;164(4):1768–1774. doi:10.4049/jimmunol.164.4.1768.
  • Richer MJ, Nolz JC, Harty JT. Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling. Immunity. 2013;38(1):140–152. doi:10.1016/j.immuni.2012.09.017.
  • Hommel M, Hodgkin PD. TCR affinity promotes CD8+ T cell expansion by regulating survival. J Immunol. 2007;179(4):2250–2260. doi:10.4049/jimmunol.179.4.2250.
  • Broome HE, Dargan CM, Krajewski S, Reed JC. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol. 1995;155:2311–2317.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.